Know Cancer

or
forgot password

Concordance Study for Amplification Detection of Her2 FISH in Breast Tissue Sections


N/A
21 Years
N/A
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information

Concordance Study for Amplification Detection of Her2 FISH in Breast Tissue Sections


Inclusion Criteria:



- Well stained breast tissue slides with bright Her2 signals

Exclusion Criteria:

- Very old slides that were already bleached

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Retrospective

Principal Investigator

Sheila Dobin, Ph.D.

Investigator Role:

Study Director

Investigator Affiliation:

Section Chief, Cytogenetics

Authority:

United States: Institutional Review Board

Study ID:

ASI-Her2F

NCT ID:

NCT01066507

Start Date:

July 2008

Completion Date:

January 2010

Related Keywords:

  • Breast Cancer
  • Her2
  • FISH
  • Breast cancer
  • Amplification
  • Breast Neoplasms

Name

Location

PLUS DiagnosticsLakewood, New Jersey  08701
Scott & White Hospital, TexasTemple, Texas  76508